Human Epidermal Growth Factor Receptor 2 (HER2) Negative Gastric, Gastroesophageal Junction (GEJ), or Esophageal Cancer

Details

Files
Project Status:
Complete
Therapeutic Area:
Esophageal or Gastroesophageal Junction Cancer
Project Line:
Reimbursement Review
Project Sub Line:
Provisional Funding Algorithm
Project Number:
PH0010-000

Review Type: Panel

Provisional Funding Algorithm

Stakeholder Input Deadline: April 7, 2022
Draft Report Posted: May 12, 2022
Stakeholder Feedback Deadline: May 19, 2022
Final Report Posted : June 21, 2022